Xi Liu

State Key Laboratory For Diagnosis And Treatment Of Infectious Diseases
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

PGK1 Suppresses CD8+ T Cell-Mediated Antitumor Immunity Through CCL2/CCR2/Tumor-Associated Macrophages Axis in Hepatocellular Carcinoma.

PGK1 Suppresses CD8+ T Cell-Mediated Antitumor Immunity Through CCL2/CCR2/Tumor-Associated Macrophages Axis in Hepatocellular Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 07, 2025

Targeting MSR1+ tumor-associated macrophages enhances the therapeutic efficacy of anti-PD-L1 in hepatocellular carcinoma by suppressing NF-κB pathway activation.

Targeting MSR1+ tumor-associated macrophages enhances the therapeutic efficacy of anti-PD-L1 in hepatocellular carcinoma by suppressing NF-κB pathway activation.

Journal: Cancer letters

Published: November 20, 2025

Galectin-1-Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs.

Galectin-1-Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 29, 2024

Author Correction: Light and matter co-confined multi-photon lithography.

Author Correction: Light and matter co-confined multi-photon lithography.

Journal: Nature communications

Published: May 03, 2024

Nanosecond pulsed electric field stimulates CD103+ DC accumulation in tumor microenvironment via NK-CD103+ DC crosstalk.

Nanosecond pulsed electric field stimulates CD103+ DC accumulation in tumor microenvironment via NK-CD103+ DC crosstalk.

Journal: Cancer letters

Published: September 14, 2023

Light and matter co-confined multi-photon lithography.

Light and matter co-confined multi-photon lithography.

Journal: Nature communications

Published: June 12, 2023

Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway.

Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway.

Journal: Cancer letters

Published: June 08, 2023

A macropinocytosis-related gene signature predicts the prognosis and immune microenvironment in hepatocellular carcinoma.

A macropinocytosis-related gene signature predicts the prognosis and immune microenvironment in hepatocellular carcinoma.

Journal: Frontiers in oncology

Published: January 12, 2023

DBF4 Dependent Kinase Inhibition Suppresses Hepatocellular Carcinoma Progression and Potentiates Anti-Programmed Cell Death-1 Therapy.

DBF4 Dependent Kinase Inhibition Suppresses Hepatocellular Carcinoma Progression and Potentiates Anti-Programmed Cell Death-1 Therapy.

Journal: International journal of biological sciences

Published: October 31, 2022

Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study.

Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT

Published: March 17, 2021

A Nomogram Estimation for the Risk of Microvascular Invasion in Hepatocellular Carcinoma Patients Meeting the Milan Criteria.

A Nomogram Estimation for the Risk of Microvascular Invasion in Hepatocellular Carcinoma Patients Meeting the Milan Criteria.

Journal: Journal of investigative surgery : the official journal of the Academy of Surgical Research

Published: March 03, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026